This inventor holds 61 USPTO granted patents and 20 published patent applications and 26 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Medshine Discovery Inc., Shandong Danhong Pharmaceutical Co., Ltd.. Active years: 2013-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Jiangsu, CN (2018)
- Lianyungang, CN (2019)
- Nanjing, CN (2021 - 2022)
- Shanghai, CN (2013 - 2024)
Company Filing History:
8 out of 121 
8 out of 72 
6 out of 10 
Years Active: 2013-2026
Areas of Expertise:
Title: The Innovative Contributions of Haiying He in Pharmaceutical Patents
Introduction: Haiying He, based in Shanghai, China, is a prominent inventor with a remarkable portfolio of 48 patents. His work significantly contributes to the field of pharmaceuticals, particularly in the development of new medications for various health conditions.
Latest Patents: Among his latest innovations are two notable patents. The first is titled "Solid form, crystalline form, and crystal form A of FXR agonist, and preparation method and application thereof." This patent discloses a solid form, a crystalline form, and a crystal form A of a specific compound used as an FXR agonist, along with its preparation method. The patent highlights the compound's application in developing medications for treating nonalcoholic steatohepatitis (NASH). The second patent focuses on a "Ring-modified proline short peptide compound and use thereof." This patent describes a ring-modified proline short peptide compound and its utilization, providing a compound represented by a specified formula or a pharmaceutically acceptable salt.
Career Highlights: Haiying He's professional journey includes significant roles at well-known pharmaceutical companies. He has worked with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Medshine Discovery Inc., where he contributed to various research and development projects that have advanced pharmaceutical innovation.
Collaborations: Throughout his career, He has collaborated with experts in the field, including notable coworkers such as Shuhui Chen and Zhigan Jiang. These collaborations have fostered an environment of shared knowledge and innovation that has benefitted their respective projects and the pharmaceutical industry as a whole.
Conclusion: Haiying He's dedication to pharmaceutical innovation is reflected in his impressive number of patents and the innovative solutions he has developed. His contributions, particularly concerning treatments for conditions like NASH, underscore the importance of continuous research and development in healthcare advancements. The future promises to hold even more impactful inventions from this talented inventor as he continues to push the boundaries of pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile